WallStSmart

MiniMed Group, Inc. Common Stock (MMED)vsTalkspace Inc (TALK)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

MiniMed Group, Inc. Common Stock generates 1161% more annual revenue ($2.89B vs $228.87M). TALK leads profitability with a 3.4% profit margin vs -7.3%. TALK earns a higher WallStSmart Score of 45/100 (D).

MMED

Hold

37

out of 100

Grade: F

Growth: 5.3Profit: 3.5Value: 5.0Quality: 5.0

TALK

Hold

45

out of 100

Grade: D

Growth: 7.3Profit: 4.5Value: 3.0Quality: 7.8
Piotroski: 4/9Altman Z: 3.95
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for MMED.

TALKSignificantly Overvalued (-102.1%)

Margin of Safety

-102.1%

Fair Value

$1.87

Current Price

$5.13

$3.26 premium

UndervaluedFair: $1.87Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

MMED0 strengths · Avg: 0/10

No standout strengths identified

TALK2 strengths · Avg: 9.0/10
Altman Z-ScoreHealth
3.9510/10

Safe zone — low bankruptcy risk

Revenue GrowthGrowth
29.3%8/10

Revenue surging 29.3% year-over-year

Areas to Watch

MMED4 concerns · Avg: 3.0/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Return on EquityProfitability
0.0%3/10

ROE of 0.0% — below average capital efficiency

Operating MarginProfitability
1.4%3/10

Operating margin of 1.4%

Free Cash FlowQuality
$-53.00M2/10

Negative free cash flow — burning cash

TALK4 concerns · Avg: 3.3/10
EPS GrowthGrowth
1.8%4/10

1.8% earnings growth

Market CapQuality
$857.10M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
6.7%3/10

ROE of 6.7% — below average capital efficiency

Profit MarginProfitability
3.4%3/10

3.4% margin — thin

Comparative Analysis Report

WallStSmart Research

Bull Case : MMED

Revenue growth of 13.1% demonstrates continued momentum.

Bull Case : TALK

The strongest argument for TALK centers on Altman Z-Score, Revenue Growth. Revenue growth of 29.3% demonstrates continued momentum.

Bear Case : MMED

The primary concerns for MMED are EPS Growth, Return on Equity, Operating Margin.

Bear Case : TALK

The primary concerns for TALK are EPS Growth, Market Cap, Return on Equity. A P/E of 128.3x leaves little room for execution misses. Thin 3.4% margins leave little buffer for downturns.

Key Dynamics to Monitor

MMED profiles as a turnaround stock while TALK is a growth play — different risk/reward profiles.

TALK is growing revenue faster at 29.3% — sustainability is the question.

TALK generates stronger free cash flow (2M), providing more financial flexibility.

Monitor HEALTH INFORMATION SERVICES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

TALK scores higher overall (45/100 vs 37/100) and 29.3% revenue growth. Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

MiniMed Group, Inc. Common Stock

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

Minimed Group, Inc. is a medical technology company that develops, manufactures, and markets medical equipment for the management of diabetes. The company is headquartered in Northridge, California.

Talkspace Inc

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

Talkspace Inc. is a virtual behavioral healthcare company. The company is headquartered in New York, New York.

Want to dig deeper into these stocks?